{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:14:15Z","timestamp":1790691255310,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/inf.0b013e3182064bfe","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T00:45:37Z","timestamp":1295397937000},"page":"218-221","source":"Crossref","is-referenced-by-count":46,"title":["Intravenous Colistin Administration in Neonates"],"prefix":"10.1097","volume":"30","author":[{"given":"Mamta","family":"Jajoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210202","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1542\/peds.2004-1785","article-title":"Is bloodstream infection preventable among premature infants? A tale of two cities.","volume":"115","author":"Aly","year":"2005","journal-title":"Pediatrics"},{"key":"R2-8-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network.","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"issue":"suppl 4","key":"R3-8-20210202","doi-asserted-by":"crossref","first-page":"N64","DOI":"10.1097\/00003246-200104001-00002","article-title":"Increasing prevalence of antimicrobial resistance in intensive care units.","volume":"29","author":"Fridkin","year":"2001","journal-title":"Crit Care Med"},{"key":"R4-8-20210202","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2146\/ajhp060473","article-title":"Polymyxin antibiotics for gram-negative infections.","volume":"64","author":"Arnold","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"R5-8-20210202","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-72-6-857","article-title":"Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy.","volume":"72","author":"Koch-Weser","year":"1970","journal-title":"Ann Intern Med"},{"key":"R6-8-20210202","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijantimicag.2008.10.021","article-title":"Systemic colistin use in children without cystic fibrosis: a systematic review of the literature.","volume":"33","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R7-8-20210202","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00431-009-1137-3","article-title":"Colistin administration to pediatric and neonatal patients.","volume":"169","author":"Iosifidis","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R8-8-20210202","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R9-8-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0972-5229.56048","article-title":"Colistin and polymyxin B: a re-emergence.","volume":"13","author":"Gupta","year":"2009","journal-title":"Indian J Crit Care Med"},{"key":"R10-8-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0972-5229.45074","article-title":"Safety and efficacy of polymyxin B in multidrug resistant gram-negative severe sepsis and septic shock.","volume":"12","author":"Ramasubban","year":"2008","journal-title":"Indian J Crit Care Med"},{"key":"R11-8-20210202","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxin revisited.","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"R12-8-20210202","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijid.2006.09.011","article-title":"Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.","volume":"11","author":"Koomanachai","year":"2007","journal-title":"Int J Infect Dis"},{"key":"R13-8-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1469-0691.2004.01043.x","article-title":"Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: the renaissance of an old antibiotic.","volume":"11","author":"Michalopoulos","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"R14-8-20210202","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.49.8.3136-3146.2005","article-title":"Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis.","volume":"49","author":"Kasiakou","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-8-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/374337","article-title":"Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.","volume":"36","author":"Garnacho-Montero","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R16-8-20210202","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/cc2358","article-title":"Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients.","volume":"7","author":"Markou","year":"2003","journal-title":"Crit Care"},{"key":"R17-8-20210202","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa.","volume":"37","author":"Linden","year":"","journal-title":"Clin Infect Dis"},{"key":"R18-8-20210202","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.","volume":"28","author":"Levin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R19-8-20210202","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BCR.0b013e3181abffb6","article-title":"Use of colistin in a pediatric burn unit in Argentina.","volume":"30","author":"Rosanova","year":"2009","journal-title":"J Burn Care Res"},{"key":"R20-8-20210202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/BCR.0B013E318053D346","article-title":"Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population.","volume":"28","author":"Goverman","year":"2007","journal-title":"J Burn Care Res"},{"key":"R21-8-20210202","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/INF.0b013e31818a5dbd","article-title":"Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.","volume":"28","author":"Falgas","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R22-8-20210202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1179\/146532809X440761","article-title":"Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin.","volume":"29","author":"Dalgic","year":"2009","journal-title":"Ann Trop Paediatr"},{"key":"R23-8-20210202","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/INF.0b013e3181ac4980","article-title":"Use of colistin in children.","volume":"28","author":"Tamma","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R24-8-20210202","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1442-200X.2008.02677.x","article-title":"Multidrug-resistant Acinetobacter meningitis in a 3-year-old boy treated with i. v. colistin.","volume":"50","author":"Lee","year":"2008","journal-title":"Pediatr Int"},{"key":"R25-8-20210202","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jac\/dkl347","article-title":"Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.","volume":"58","author":"Ng","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R26-8-20210202","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/AAC.47.3.905-909.2003","article-title":"Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model.","volume":"47","author":"Gunderson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-8-20210202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM196204122661505","article-title":"Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.","volume":"266","author":"Wolinsky","year":"1962","journal-title":"N Engl J Med"},{"key":"R28-8-20210202","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1046\/j.1523-1755.2002.00509.x","article-title":"Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes.","volume":"62","author":"Clermont","year":"2002","journal-title":"Kidney Int"},{"key":"R29-8-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant gram-negative bacteria.","volume":"25","author":"Li","year":"2005","journal-title":"Int J Antimicrob Agents"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e3182064bfe","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:52:47Z","timestamp":1786042367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201103000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182064bfe","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}